170 related articles for article (PubMed ID: 33337496)
1. Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program in the First 22 Months of Implementation.
Mera J; Williams MB; Essex W; McGrew KM; Boeckman L; Gahn D; Miller A; Durham D; Fox J; David C; Ritter T; Jones S; Bouse S; Galvani A; Ward JW; Drevets DA; Carabin H
JAMA Netw Open; 2020 Dec; 3(12):e2030427. PubMed ID: 33337496
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program - Cherokee Nation, Oklahoma, 2015-2020.
Essex W; Feder M; Mera J
MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(22):597-600. PubMed ID: 37262000
[TBL] [Abstract][Full Text] [Related]
3. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
[TBL] [Abstract][Full Text] [Related]
4. Assessing the Feasibility, Acceptability, and Effectiveness of a Pilot Hepatitis C Screening Program at Food Distribution Sites in Cherokee Nation, Oklahoma.
Essex W; Mera J; Comiford A; Winters A; Feder MA
J Community Health; 2023 Dec; 48(6):982-993. PubMed ID: 37531046
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
[TBL] [Abstract][Full Text] [Related]
7. Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?
Kondili LA; Blach S; Razavi H; Craxì A
Ann Ist Super Sanita; 2020; 56(3):325-329. PubMed ID: 32959798
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
[TBL] [Abstract][Full Text] [Related]
9. Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs - Georgia, 2018.
Stvilia K; Spradling PR; Asatiani A; Gogia M; Kutateladze K; Butsashvili M; Zarkua J; Tsertsvadze T; Sharvadze L; Japaridze M; Kuchuloria T; Gvinjilia L; Tskhomelidze I; Gamkrelidze A; Khonelidze I; Sergeenko D; Shadaker S; Averhoff F; Nasrullah M
MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(29):637-641. PubMed ID: 31344021
[TBL] [Abstract][Full Text] [Related]
10. Innovations in Hepatitis C Screening and Treatment.
Patel AA; Bui A; Prohl E; Bhattacharya D; Wang S; Branch AD; Perumalswami PV
Hepatol Commun; 2021 Mar; 5(3):371-386. PubMed ID: 33681673
[TBL] [Abstract][Full Text] [Related]
11. Lessons Learned From Global Hepatitis C Elimination Programs.
Handanagic S; Shadaker S; Drobeniuc J; Tsereteli M; Alkhazashvili M; Adesigbin C; Adamu I; Adabe R; Agwuocha C; Adisa O; Azania A; Boeke CE; Ngwije A; Serumondo J; Armstrong PA
J Infect Dis; 2024 May; 229(Supplement_3):S334-S341. PubMed ID: 37739781
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Disease Burden and Outcomes Among American Indian and Alaska Native Medicare Beneficiaries.
Eberly LA; Shultz K; Merino M; Brueckner MY; Benally E; Tennison A; Biggs S; Hardie L; Tian Y; Nathan AS; Khatana SAM; Shea JA; Lewis E; Bukhman G; Shin S; Groeneveld PW
JAMA Netw Open; 2023 Sep; 6(9):e2334923. PubMed ID: 37738051
[TBL] [Abstract][Full Text] [Related]
13. Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study.
Olafsson S; Fridriksdottir RH; Love TJ; Tyrfingsson T; Runarsdottir V; Hansdottir I; Bergmann OM; Björnsson ES; Johannsson B; Sigurdardottir B; Löve A; Baldvinsdottir GE; Hernandez UB; Gudnason T; Heimisdottir M; Hellard M; Gottfredsson M
Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):628-637. PubMed ID: 34171267
[TBL] [Abstract][Full Text] [Related]
14. A Population-Based Intervention to Improve Care Cascades of Patients With Hepatitis C Virus Infection.
Scott J; Fagalde M; Baer A; Glick S; Barash E; Armstrong H; Kowdley KV; Golden MR; Millman AJ; Nelson NP; Canary L; Messerschmidt M; Patel P; Ninburg M; Duchin J
Hepatol Commun; 2021 Mar; 5(3):387-399. PubMed ID: 33681674
[TBL] [Abstract][Full Text] [Related]
15. Improved Hepatitis C Cure Cascade Outcomes Among Urban Baby Boomers in the Direct-Acting Antiviral Era.
Dupont SC; Fluker SA; Quairoli KM; Body C; Okosun I; Lom J; Miller LS
Public Health Rep; 2020 Jan; 135(1):107-113. PubMed ID: 31756116
[TBL] [Abstract][Full Text] [Related]
16. Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation.
Kondili LA; Aghemo A; Andreoni M; Galli M; Rossi A; Babudieri S; Nava F; Leonardi C; Mennini FS; Gardini I; Russo FP
Dig Liver Dis; 2022 Feb; 54(2):237-242. PubMed ID: 33926816
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C in pregnant American Indian and Alaska native women; 2003-2015.
Nolen LD; O'Malley JC; Seeman SS; Bruden DJT; Apostolou A; McMahon BJ; Bruce MG
Int J Circumpolar Health; 2019 Dec; 78(1):1608139. PubMed ID: 31025610
[TBL] [Abstract][Full Text] [Related]
18. Incidence and Progression of Diabetic Retinopathy in American Indian and Alaska Native Individuals Served by the Indian Health Service, 2015-2019.
Fonda SJ; Bursell SE; Lewis DG; Clary D; Shahon D; Cavallerano J
JAMA Ophthalmol; 2023 Apr; 141(4):366-375. PubMed ID: 36892822
[TBL] [Abstract][Full Text] [Related]
19. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
[TBL] [Abstract][Full Text] [Related]
20. Using the Diabetes Care System for a County-Wide Hepatitis C Elimination: An Integrated Community-Based Shared Care Model in Taiwan.
Hu TH; Luh DL; Tsao YY; Lin TY; Chang CJ; Su WW; Yang CC; Yang CJ; Chen HP; Liao PY; Su SL; Chen LS; Hsiu-Hsi Chen T; Yeh YP;
Am J Gastroenterol; 2024 May; 119(5):883-892. PubMed ID: 38084857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
